Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Laura Bannach Jardim, Hospital de Clinicas de Porto Alegre
ClinicalTrials.gov Identifier:
NCT01096082
First received: March 29, 2010
Last updated: January 29, 2013
Last verified: January 2013